Bz-Val-Gly-Arg-AMC Trifluoroacetate combines a benzoylated peptide sequence with a fluorogenic coumarin analog to assess protease activity. Valine and arginine define hydrophobic and basic recognition elements. Researchers monitor fluorescence release to quantify enzymatic specificity. Uses include substrate profiling, kinetic assays, and mechanistic evaluation.
CAT No: R2552
CAS No:2237216-34-9
Synonyms/Alias:Bz-Val-Gly-Arg-AMC trifluoroacetate;201851-44-7;2237216-34-9;N-((S)-1-((2-(((S)-5-Guanidino-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)amino)-2-oxoethyl)amino)-3-methyl-1-oxobutan-2-yl)benzamide 2,2,2-trifluoroacetate;MFCD02259608;G90672;N-[(2S)-1-[[2-[[(2S)-5-(diaminomethylideneamino)-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]benzamide;2,2,2-trifluoroacetic acid;
1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
3. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.